Top 3 Episodes of 2022 - #1 Dame Kate Bingham (Managing Partner of SV Health Investors)
Mar 22, 2023
auto_awesome
Dame Kate Bingham, Managing Partner of SV Health Investors, discusses advancements in medical research, challenges in building biotech enterprises, and her role in the UK Vaccine Taskforce. She reflects on obstacles faced during the COVID-19 vaccine distribution and the future of the industry landscape.
Medical research advancements enable changing body functions, not just treating symptoms.
SV Health Investors facilitates leaps in medical conditions with research excellence.
Future healthcare may include early diagnosis, personalized medicine, and impact investing.
Gender diversity in biotech and finance emphasized, empowering women in leadership roles.
Deep dives
The Power of Asking in Business Growth
Emphasizing the importance of communication in business success, the podcast discusses the significance of the phrase 'just ask' in boosting assets and setting ambitious targets for business growth.
Innovative Companies and Sponsorship Collaboration
Exploring corporate partnerships, the podcast delves into collaborations with sponsors like Schroeder's and Bremont, highlighting the investment management solutions provided by Schroeder's and the innovative luxury wristwatches designed by Bremont.
Venturing into Biotech and Healthcare with Dame Kate Bingham
Featuring an interview with Dame Kate Bingham, the podcast delves into venture investing in biotech and healthcare, discussing Dame Kate's journey from studying biochemistry to becoming a managing partner at a life sciences venture capital firm and her pivotal role in the UK Vaccine Task Force.
Innovations in Drug Discovery and Precision Medicine
Exploring advancements in drug discovery and precision medicine, the podcast sheds light on the evolution of pharmaceuticals from traditional oral medicines to antibody-based drugs, mRNA vaccines, cell and gene therapies, and CRISPR technology, revolutionizing treatment approaches.
The Future of Healthcare Landscape and Impact Investing
Discussing the future of healthcare, the podcast envisions a landscape where early diagnosis, preventive healthcare, and personalized medicine play vital roles in extending health span, emphasizing the importance of impact investing in driving positive change.
Encouraging Women in Finance and Science
Addressing gender diversity in biotech and venture capital, the podcast underscores the need for more women in STEM subjects and finance, highlighting the importance of empowering women in leadership roles and fostering diversity in the industry.
Crisis Management and Preparedness for Future Pandemics
Reflecting on crisis management during the COVID-19 pandemic, the podcast emphasizes the need for a dedicated pandemic chief in government, strategic partnerships with industry, agility in regulatory processes, and lessons learned for future preparedness.
Favorite Daily Habit, Life Lessons, and Musical Choice
Sharing personal insights, the podcast touches on Kate Bingham's favorite daily habit of cycling, advice to her younger self to explore new opportunities and set ambitious goals, and her choice of the book 'Fine Balance' and energetic musical piece 'Dance En Numbre 4' by Marquez.
To celebrate the three year anniversary of the Money Maze Podcast we’re pleased to be re-sharing our the top 3 most listened to episodes of 2022!
In this much anticipated interview, we are thrilled to feature Dame Kate Bingham, Managing Partner of SV Health Investors and former Chair of the UK Vaccine Taskforce.
The conversation begins with a high level overview of the immense changes that are taking place in the world of medical research which have allowed us to move from treating symptoms to changing the way the body works.
Kate describes the various leaps forward across medical conditions and the role SV Health Investors is playing to facilitate this. She discusses their approach, challenges, opportunities and the skills needed to improve the odds of success.
She then talks about research excellence, the hurdles in building large biotech enterprises and what the future industry landscape may look like.
The conversation then switches to her role as Chair of the Vaccine Taskforce, set up in April 2020 under Boris Johnson to co-ordinate the creation and distribution of a COVID-19 vaccine (both in the UK and internationally). She reflects on the obstacles encountered and path to the successful execution of the group’s objectives. Originally released in November 2022.
